Cargando…

Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy

OBJECTIVE: Diabetes can affect the eye in many ways beyond retinopathy. This study sought to evaluate ocular disease and determine any associations with peripheral neuropathy (PN) or cardiac autonomic neuropathy (CAN) in type 2 diabetes (T2D) and Charcot arthropathy (CA) patients. DESIGN: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Trindade, Marilia, Castro de Vasconcelos, Jessica, Ayub, Gabriel, Grupenmacher, Alex Treiger, Gomes Huarachi, Delma Regina, Viturino, Marina, Correa-Giannella, Maria Lucia, Atala, Yeelen Ballesteros, Zantut-Wittmann, Denise Engelbrecht, Parisi, Maria Candida, Alves, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097086/
https://www.ncbi.nlm.nih.gov/pubmed/33967949
http://dx.doi.org/10.3389/fendo.2021.585823
_version_ 1783688281915916288
author Trindade, Marilia
Castro de Vasconcelos, Jessica
Ayub, Gabriel
Grupenmacher, Alex Treiger
Gomes Huarachi, Delma Regina
Viturino, Marina
Correa-Giannella, Maria Lucia
Atala, Yeelen Ballesteros
Zantut-Wittmann, Denise Engelbrecht
Parisi, Maria Candida
Alves, Monica
author_facet Trindade, Marilia
Castro de Vasconcelos, Jessica
Ayub, Gabriel
Grupenmacher, Alex Treiger
Gomes Huarachi, Delma Regina
Viturino, Marina
Correa-Giannella, Maria Lucia
Atala, Yeelen Ballesteros
Zantut-Wittmann, Denise Engelbrecht
Parisi, Maria Candida
Alves, Monica
author_sort Trindade, Marilia
collection PubMed
description OBJECTIVE: Diabetes can affect the eye in many ways beyond retinopathy. This study sought to evaluate ocular disease and determine any associations with peripheral neuropathy (PN) or cardiac autonomic neuropathy (CAN) in type 2 diabetes (T2D) and Charcot arthropathy (CA) patients. DESIGN: A total of 60 participants were included, 16 of whom were individuals with T2D/CA, 21 of whom were individuals with T2D who did not have CA, and 23 of whom were healthy controls. Ocular surface evaluations were performed, and cases of dry eye disease (DED) were determined using the Ocular Surface Disease Index (OSDI) questionnaire, ocular surface staining, Schirmer test, and Oculus Keratograph 5M exams. All variables were used to classify DED and ocular surface disorders such as aqueous deficiency, lipid deficiency, inflammation, and ocular surface damage. Pupillary and retinal nerve fiber measurements were added to the protocol in order to broaden the scope of the neurosensory ocular evaluation. PN and CAN were ascertained by clinical examinations involving the Neuropathy Disability Score (for PN) and Ewing’s battery (for CAN). RESULTS: Most ocular variables evaluated herein differed significantly between T2D patients and controls. When the controls were respectively compared to patients with T2D and to patients with both T2D and CA, they differed substantially in terms of visual acuity (0.92 ± 0.11, 0.73 ± 0.27, and 0.47 ± 0.26, p=0.001), retinal nerve fiber layer thickness (96.83 ± 6.91, 89.25 ± 10.44, and 80.37 ± 11.67 µm, p=0.03), pupillometry results (4.10 ± 0.61, 3.48 ± 0.88, and 2.75 ± 0.81 mm, p=0.0001), and dry eye symptoms (9.19 ± 11.71, 19.83 ± 19.08, and 24.82 ± 24.40, p=0.03). DED and ocular surface damage also differed between individuals with and without CA, and were associated with PN and CAN. CONCLUSION: CA was found to be significantly associated with the severity of ocular findings. DED in cases of CA was also associated with PN and CAN. These findings suggest that intrinsic and complex neurosensory impairment in the eyes, peripheral sensory nerves, and the autonomic nervous system are somehow connected. Thus, a thorough ocular evaluation may be useful to highlight neurological complications and the impact of diabetes on ocular and systemic functions and structures.
format Online
Article
Text
id pubmed-8097086
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80970862021-05-06 Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy Trindade, Marilia Castro de Vasconcelos, Jessica Ayub, Gabriel Grupenmacher, Alex Treiger Gomes Huarachi, Delma Regina Viturino, Marina Correa-Giannella, Maria Lucia Atala, Yeelen Ballesteros Zantut-Wittmann, Denise Engelbrecht Parisi, Maria Candida Alves, Monica Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Diabetes can affect the eye in many ways beyond retinopathy. This study sought to evaluate ocular disease and determine any associations with peripheral neuropathy (PN) or cardiac autonomic neuropathy (CAN) in type 2 diabetes (T2D) and Charcot arthropathy (CA) patients. DESIGN: A total of 60 participants were included, 16 of whom were individuals with T2D/CA, 21 of whom were individuals with T2D who did not have CA, and 23 of whom were healthy controls. Ocular surface evaluations were performed, and cases of dry eye disease (DED) were determined using the Ocular Surface Disease Index (OSDI) questionnaire, ocular surface staining, Schirmer test, and Oculus Keratograph 5M exams. All variables were used to classify DED and ocular surface disorders such as aqueous deficiency, lipid deficiency, inflammation, and ocular surface damage. Pupillary and retinal nerve fiber measurements were added to the protocol in order to broaden the scope of the neurosensory ocular evaluation. PN and CAN were ascertained by clinical examinations involving the Neuropathy Disability Score (for PN) and Ewing’s battery (for CAN). RESULTS: Most ocular variables evaluated herein differed significantly between T2D patients and controls. When the controls were respectively compared to patients with T2D and to patients with both T2D and CA, they differed substantially in terms of visual acuity (0.92 ± 0.11, 0.73 ± 0.27, and 0.47 ± 0.26, p=0.001), retinal nerve fiber layer thickness (96.83 ± 6.91, 89.25 ± 10.44, and 80.37 ± 11.67 µm, p=0.03), pupillometry results (4.10 ± 0.61, 3.48 ± 0.88, and 2.75 ± 0.81 mm, p=0.0001), and dry eye symptoms (9.19 ± 11.71, 19.83 ± 19.08, and 24.82 ± 24.40, p=0.03). DED and ocular surface damage also differed between individuals with and without CA, and were associated with PN and CAN. CONCLUSION: CA was found to be significantly associated with the severity of ocular findings. DED in cases of CA was also associated with PN and CAN. These findings suggest that intrinsic and complex neurosensory impairment in the eyes, peripheral sensory nerves, and the autonomic nervous system are somehow connected. Thus, a thorough ocular evaluation may be useful to highlight neurological complications and the impact of diabetes on ocular and systemic functions and structures. Frontiers Media S.A. 2021-04-21 /pmc/articles/PMC8097086/ /pubmed/33967949 http://dx.doi.org/10.3389/fendo.2021.585823 Text en Copyright © 2021 Trindade, Castro de Vasconcelos, Ayub, Grupenmacher, Gomes Huarachi, Viturino, Correa-Giannella, Atala, Zantut-Wittmann, Parisi and Alves https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Trindade, Marilia
Castro de Vasconcelos, Jessica
Ayub, Gabriel
Grupenmacher, Alex Treiger
Gomes Huarachi, Delma Regina
Viturino, Marina
Correa-Giannella, Maria Lucia
Atala, Yeelen Ballesteros
Zantut-Wittmann, Denise Engelbrecht
Parisi, Maria Candida
Alves, Monica
Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy
title Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy
title_full Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy
title_fullStr Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy
title_full_unstemmed Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy
title_short Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy
title_sort ocular manifestations and neuropathy in type 2 diabetes patients with charcot arthropathy
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097086/
https://www.ncbi.nlm.nih.gov/pubmed/33967949
http://dx.doi.org/10.3389/fendo.2021.585823
work_keys_str_mv AT trindademarilia ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT castrodevasconcelosjessica ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT ayubgabriel ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT grupenmacheralextreiger ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT gomeshuarachidelmaregina ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT viturinomarina ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT correagiannellamarialucia ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT atalayeelenballesteros ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT zantutwittmanndeniseengelbrecht ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT parisimariacandida ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy
AT alvesmonica ocularmanifestationsandneuropathyintype2diabetespatientswithcharcotarthropathy